COCH (Envoy Medical) Institutional Ownership: 22.43% (As of Aug. 15, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

COCH Envoy Medical Inc COCH
6 GF Score
Price $0.80
GF Value $0.67
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is Envoy Medical Institutional Ownership?

Envoy Medical COCH +6.68% 6 Institutional Ownership is 22.43% as of Aug. 15, 2026. GuruFocus rates COCH with a GF Score™ of 6/100 and a GF Value™ of $0.67 (Modestly Overvalued). The stock has 8 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Envoy Medical's institutional ownership is 22.43%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Envoy Medical's Insider Ownership is 31.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Envoy Medical's Float Percentage Of Total Shares Outstanding is 59.71%.

Envoy Medical Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Envoy Medical's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Envoy Medical Institutional Ownership Chart

Envoy Medical Historical Data

The historical data trend for Envoy Medical can be seen below:

2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31
Institutional Ownership 4.28 4.28 4.03 3.76 3.67 6.54 6.63 6.57 1.76 1.76
COCH
6GF Score
Envoy Medical Inc COCH
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Envoy Medical Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 22.43% mean?
Envoy Medical (COCH) has a Institutional Ownership of 22.43% as of Aug. 15, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Envoy Medical and its competitors.
Is Envoy Medical's Institutional Ownership too high?
Envoy Medical's current Institutional Ownership is 22.43%. Overall, Envoy Medical has a GF Score™ of 6/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Envoy Medical's Institutional Ownership compare to ECOR and MDAI?
Envoy Medical's Institutional Ownership of 22.43% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Medical Devices & Instruments company?
A good Institutional Ownership depends on the Medical Devices & Instruments industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Envoy Medical and its competitors. Envoy Medical's current Institutional Ownership is 22.43%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Envoy Medical stock overvalued right now?
Based on GuruFocus' analysis, Envoy Medical (COCH) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.67, compared to a current price of $0.80 — trading 19.4% above its estimated fair value. The current Institutional Ownership is 22.43%. Envoy Medical's overall GF Score™ is 6/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Envoy Medical (COCH), the current Institutional Ownership is 22.43% as of Aug. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Envoy Medical (COCH) Overvalued in 2026?

Based on GuruFocus' analysis, Envoy Medical stock appears to be overvalued. The current stock price of $0.80 is trading 19.4% above its estimated GF Value™ of $0.67. GuruFocus considers Envoy Medical to be Modestly Overvalued.

Key valuation signals for COCH:

  • Institutional Ownership: 22.43%
  • GF Value™: $0.67 vs. price of $0.80 (19.4% above fair value)
  • GF Score™: 6/100 with 8 warning signs

No single metric tells the full story. See the COCH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Envoy Medical Business Description

Address 4875 White Bear Parkway, White Bear Lake, MN, USA, 55110
Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.
6GF Score

Get the complete analysis for COCH

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.80
Price
$0.67
GF Value